Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Madrid
Clinical trial register · Spain

Clinical Trials in Madrid, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5925 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:19 UTC
5925
Studies in scope
all four open statuses
3119
Recruiting now
open to new participants
1134
Lead sponsors
across recruiting studies
Top sites
Barcelona 18 Madrid 17 Málaga 7 Seville 7 Multiple Locations 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca185 Janssen Research & Development, LLC108 Merck Sharp & Dohme LLC106 Novartis Pharmaceuticals99 Hoffmann-La Roche89 AbbVie78 Eli Lilly and Company68 Bristol-Myers Squibb63 Pfizer61 GlaxoSmithKline56 Boehringer Ingelheim42 Sanofi42 Amgen39 Universidad Complutense de Madrid34 Daiichi Sankyo31 Incyte Corporation28 Novo Nordisk A/S27 Takeda25 Gilead Sciences25 Regeneron Pharmaceuticals23 Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal22 Genmab22 European Organisation for Research and Treatment of Cancer - EORTC21 Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz19 Bayer17 BeOne Medicines16 Ipsen15 Abbott Medical Devices15 Celgene15 BioNTech SE14 Hospital San Carlos, Madrid14 Taiho Oncology, Inc.12 Boston Scientific Corporation12 Seagen, a wholly owned subsidiary of Pfizer12 Astellas Pharma Global Development, Inc.11 argenx11 Genentech, Inc.11 Exelixis10 Alexion Pharmaceuticals, Inc.10 EMD Serono Research & Development Institute, Inc.10 Hospital Universitario La Paz10 UCB Biopharma SRL10 Universidad Europea de Madrid9 Clinica Universidad de Navarra, Universidad de Navarra9 PETHEMA Foundation9 Fundación de Investigación Biomédica - Hospital Universitario de La Princesa8 Institut de Recherches Internationales Servier8 Hospital Universitario 12 de Octubre8 Eisai Inc.7 Instituto de Investigación Hospital Universitario La Paz7 Jazz Pharmaceuticals7 Universidad Pontificia Comillas7 Revolution Medicines, Inc.7 Loxo Oncology, Inc.7 Hospital General Universitario Gregorio Marañon7 Pierre Fabre Medicament7 MedSIR7 ViiV Healthcare7 ETOP IBCSG Partners Foundation7 Alnylam Pharmaceuticals7 Zenas BioPharma (USA), LLC6 ModernaTX, Inc.6 University Hospital, Basel, Switzerland6 Acerta Pharma BV6 Agios Pharmaceuticals, Inc.6 Medtronic6 Mirum Pharmaceuticals, Inc.6 Deciphera Pharmaceuticals, LLC5 Alkermes, Inc.5 Servier Bio-Innovation LLC5 Hospital Universitari Vall d'Hebron Research Institute5 Replimune, Inc.5 Johnson & Johnson Enterprise Innovation Inc.5 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla5 Tesaro, Inc.5 Universidad Politecnica de Madrid5 Vertex Pharmaceuticals Incorporated5 Mirati Therapeutics Inc.5 Princess Maxima Center for Pediatric Oncology5 Infanta Leonor University Hospital5 Puerta de Hierro University Hospital5 Stemline Therapeutics, Inc.5 Fundación EPIC5 Immunocore Ltd5 Gustave Roussy, Cancer Campus, Grand Paris5 Biogen5 BicycleTx Limited5 H. Lundbeck A/S5 Verastem, Inc.5 Kite, A Gilead Company5 Xenon Pharmaceuticals Inc.5 Summit Therapeutics4 PharmaMar4 Universidad Rey Juan Carlos4 ADARx Pharmaceuticals, Inc.4 Tyra Biosciences, Inc4 Janssen Pharmaceutica N.V., Belgium4 ADVANCED MARKER DISCOVERY S.L.4 AOP Orphan Pharmaceuticals AG4 Centro Universitario La Salle4 Swedish Orphan Biovitrum4 CatalYm GmbH4 Immunovant Sciences GmbH4 Population Health Research Institute4 SOLTI Breast Cancer Research Group4 Mucosa Innovations, S.L.4 CSL Behring4 Celldex Therapeutics4 University Medical Center Groningen4 Grupo Espanol de Investigacion en Sarcomas4 Fundación para la Investigación del Hospital Clínico de Valencia4 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company4 MedImmune LLC4 Ionis Pharmaceuticals, Inc.4 Fundación de investigación HM4 Otsuka Pharmaceutical Development & Commercialization, Inc.4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company4 BioInvent International AB4 UNICANCER4 Teva Branded Pharmaceutical Products R&D LLC3 Olistic Research Labs S.L.3 Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic3 Cogent Biosciences, Inc.3 Praxis Precision Medicines3 Orion Corporation, Orion Pharma3 Nuvalent Inc.3 Ascentage Pharma Group Inc.3 University of Oxford3 Philips Clinical & Medical Affairs Global3 BAAT Medical Products B.V.3 AB Science3 Universidad de Murcia3 Longboard Pharmaceuticals3 Rocket Pharmaceuticals Inc.3 Hospital Clinic of Barcelona3 Spanish Society of Cardiology3 Sinfatin S.L3 Fundacion Clinic per a la Recerca Biomédica3 Janssen-Cilag Ltd.3 Azafaros B.V.3 Denali Therapeutics Inc.3 Sanofi Pasteur, a Sanofi Company3 iSTAR Medical3 Universidad Autonoma de Madrid3 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)3 Medtronic Cardiovascular3 Corcept Therapeutics3 Eikon Therapeutics3 Debiopharm International SA3 Avalyn Pharma Inc.3 Inhibrx Biosciences, Inc3 ALX Oncology Inc.3 USWM CT, LLC3 Consorcio Centro de Investigación Biomédica en Red (CIBER)3 Insel Gruppe AG, University Hospital Bern3 University of Siena3 MoonLake Immunotherapeutics AG3 Celcuity Inc3 AO Innovation Translation Center3 Travere Therapeutics, Inc.3 Kura Oncology, Inc.3 Instituto de Investigación Marqués de Valdecilla3 Idoven 1903 S.L.3 Stichting Hemato-Oncologie voor Volwassenen Nederland3 Grupo Espanol de Tumores Neuroendocrinos3 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau3 Alentis Therapeutics AG3 Enliven Therapeutics3 RECORDATI GROUP3 European Myeloma Network B.V.3 GRIN Therapeutics, Inc.3 IDEAYA Biosciences3 Turning Point Therapeutics, Inc.3 Vividion Therapeutics, Inc.3 IMDEA Food3 ITM Solucin GmbH3 Octapharma3 Biotronik SE & Co. KG3 Fundacion para la Innovacion en Biomedicina (FIBMED)3 Vir Biotechnology, Inc.3 Viridian Therapeutics, Inc.3 ProbiSearch SL3 Olema Oncology, Inc.3 Aragon Pharmaceuticals, Inc.3 Outcomes'103 Grupo Español Multidisciplinar de Melanoma3 European Association of Urology Research Foundation3 Pyxis Oncology, Inc3 Instituto de Investigación Biomédica de Salamanca3 Karyopharm Therapeutics Inc3 Cytokinetics3 Aristotle University Of Thessaloniki2 Biohaven Therapeutics Ltd.2 Industrial Farmacéutica Cantabria, S.A.2 Azienda Ospedaliero-Universitaria Careggi2 Ferring Pharmaceuticals2 Gerencia de Atención Primaria, Madrid2 Taewoong Medical Co., Ltd.2 Parc de Salut Mar2 Hospital Universitario Ramon y Cajal2 BioMarin Pharmaceutical2 Cristina Domínguez González2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2 Pharming Technologies B.V.2 OncoSil Medical Limited2 Akero Therapeutics, Inc2 Quell Therapeutics Limited2 Igenomix2 Zai Lab (Shanghai) Co., Ltd.2 DBV Technologies2 European University of Madrid2 Artios Pharma Ltd2 Queen Mary University of London2 Philogen S.p.A.2 Fundacio Clinic Barcelona2 Relay Therapeutics, Inc.2 Xencor, Inc.2 Merz Therapeutics GmbH2 Antonio Pérez Martínez2 Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea2 UMC Utrecht2 medac GmbH2 Kiniksa Pharmaceuticals International, plc2 Sarepta Therapeutics, Inc.2 Mats Heyman2 Glycomine, Inc.2 Copenhagen University Hospital, Rigshospitalet2 Daniel Rodríguez Muñoz2 iOnctura2 Bluefin Biomedicine, Inc.2 Calico Life Sciences LLC2 Instituto de Ciencia y Tecnología de Alimentos y Nutrición2 Guardant Health, Inc.2 Shockwave Medical, Inc.2 Epygenix2 Kumquat Biosciences Inc.2 Jesus Villar2 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2 Corbus Pharmaceuticals Inc.2 MarsiBionics2 Alleviant Medical, Inc.2 Insmed Incorporated2 Byondis B.V.2 Blueprint Medicines Corporation2 Prilenia2 Jiangsu HengRui Medicine Co., Ltd.2 IO Biotech2 Bioiberica2 Colorado Prevention Center2 Italian Sarcoma Group2 Geron Corporation2 Immunome, Inc.2 Shanghai Henlius Biotech2 Universidad Villanueva2 Target PharmaSolutions, Inc.2 Balt Extrusion2 Ad scientiam2 ARCAGY/ GINECO GROUP2 mAbxience Research S.L.2 European Foundation for Study of Chronic Liver Failure2 Lupin Ltd.2 Astellas Pharma Inc2 Ellipses Pharma2 Syndax Pharmaceuticals2 MediLink Therapeutics (Suzhou) Co., Ltd.2 Nicolas Brogly2 Spanish Breast Cancer Research Group2 Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz2 NovoCure GmbH2 Pharvaris Netherlands B.V.2 PedAL BCU, LLC2 Ryvu Therapeutics SA2 Crinetics Pharmaceuticals Inc.2 Spanish Oncology Genito-Urinary Group2 Chiesi Farmaceutici S.p.A.2 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III2 Xynomic Pharmaceuticals, Inc.2 Menoclinica by Palacios2 ADC Therapeutics S.A.2 National Research Council, Spain2 Nuvation Bio Inc.2 i+Med S.Coop.2 Oncomatryx Biopharma S.L.2 The Lymphoma Academic Research Organisation2 Noema Pharma AG2 Arcus Biosciences, Inc.2 Medtronic Cardiac Ablation Solutions2 Fundació d'investigació Sanitària de les Illes Balears2 Camilo Jose Cela University2 Zymeworks BC Inc.2 City of Hope Medical Center2 LEO Pharma2 Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León2 Actelion2 Candela Corporation2 University of Castilla-La Mancha2 Upstream Bio Inc.2 ArriVent BioPharma, Inc.2 Iovance Biotherapeutics, Inc.2 NeuroDerm Ltd.2 Amicus Therapeutics2 Vaderis Therapeutics AG2 Grupo Español de Tratamiento de Tumores de Cabeza y Cuello2 Aether Tech S.L.2 Transgene2 Astria Therapeutics, Inc.2 BioCryst Pharmaceuticals2 Grey Wolf Therapeutics2 AC Immune SA2 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2 ORIC Pharmaceuticals2 Grupo Español de Investigación en Cáncer de Ovario2 Chugai Pharmaceutical2 Apogee Therapeutics, Inc.2 University Hospital, Ghent2 Fundacion Investigacion Interhospitalaria Cardiovascular2 Cullinan Therapeutics Inc.2 Kailera2 Edwards Lifesciences2 Fundación Academia Española de Dermatología2 United Therapeutics2 Basilea Pharmaceutica2 Resolution Therapeutics Limited2 Curis, Inc.2 Arrowhead Pharmaceuticals2 Biotronik AG2 Ono Pharmaceutical Co., Ltd.2 Inmunotek S.L.2 Fundación GECP2 Foundation for Science, Health and Education, Spain2 Société des Produits Nestlé (SPN)2 W.L.Gore & Associates2 Apellis Pharmaceuticals, Inc.2 Gruppo Oncologico del Nord-Ovest2 Madrigal Pharmaceuticals, Inc.2 Technical University of Madrid2 SystImmune Inc.2 Prestige Biopharma Limited2 IDP Discovery Pharma S.L.2 UroGen Pharma Ltd.2 HiFiBiO Therapeutics2 Dizal Pharmaceuticals2 Neurocrine Biosciences2 Canadian Cancer Trials Group2 Universidade da Coruña2 Fundación Española de Hematología y Hemoterapía2 P+F Products + Features GmbH2 Tourmaline Bio, Inc., a Novartis Company1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 The European Forum for Research and Education in Allergy and Airway Diseases1 Sairopa B.V.1 Juan Ameztoy1 Alcyone Therapeutics, Inc1 Carlos Alfredo Fraile Olivero, MD, PhD.1 V-Wave Ltd1 Autolus Limited1 NS Pharma, Inc.1 Salubris Biotherapeutics Inc1 Jamil Cedeño Mora1 Bioverativ, a Sanofi company1 Solstice Oncology, Inc.1 Fundacion SEIMC-GESIDA1 Windward Bio1 Cuerpos Serranos S.L.1 Laminar Pharmaceuticals1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Stichting European Myeloma Network1 Fundació Sant Joan de Déu1 Alejandro Lucia1 TWi Biotechnology, Inc.1 Biocodex1 Prokrea BCN, S.L.1 MonTa Biosciences ApS1 Pablo Rodríguez del Rio1 Santen SAS1 Priothera SAS1 Reprieve Cardiovascular, Inc1 ExThera Medical Corporation1 Immutep S.A.S.1 Medtronic Neurovascular Clinical Affairs1 Actuate Therapeutics Inc.1 Theriva Biologics SL1 Egle Therapeutics1 Pliant Therapeutics, Inc.1 NEOS Surgery1 Sophia Genetics SAS1 NEC Bio B.V1 Marco Esposito1 Unifarco SpA1 Francisco Hernández Oliveros1 Bordeaux Colorectal Institute1 Instituto Valenciano de Infertilidad, IVI VALENCIA1 BeiGene1 Batea Oncology1 University of Michigan1 Oxford BioTherapeutics Ltd1 Óscar Cano Pérez1 VarmX B.V.1 Instituto Oncológico Dr Rosell1 University Hospital Virgen de las Nieves1 ImmunAbs Inc.1 Bicara Therapeutics1 Alliance Foundation Trials, LLC.1 Y-mAbs Therapeutics1 Queen Silvia Children's Hospital, Gothenburg, Sweden1 PPM Services S.A.1 Oncoinvent Solutions AS1 National Cancer Institute, Naples1 Oncare Madrid1 CooperVision International Limited (CVIL)1 Eclipse Medical Ltd.1 enGene, Inc.1 Mikrobiomik Healthcare Company S.L.1 Atavistik Bio, Inc1 Advenchen Pharmaceuticals, LLC.1 Oils4Cure1 Kyowa Kirin Pharmaceutical Development Ltd1 Philipp Schuetz1 Tectonic Operating Company, Inc.1 Agenus Inc.1 Mitera Hospital1 Humanitas Hospital, Italy1 Renaissance Pharma Ltd.1 HepaRegeniX GmbH1 Mundipharma Research Limited1 Nurix Therapeutics, Inc.1 Fundación San Juan De Dios1 D3 Bio (Wuxi) Co., Ltd1 Hifas da Terra S.L.1 GWT-TUD GmbH1 Aimmune Nestlé Health Science US R&D, LLC1 University of Massachusetts, Worcester1 Centro de Miopía Fernández-Velázquez1 Procare Health Iberia S.L.1 Loulou Foundation1 Guillermo Galeote; MD, PhD1 Medtronic - MITG1 Janssen Scientific Affairs, LLC1 Inrobics Social Robotics, S.L.1 Repertoire Immune Medicines1 Avidity Biosciences, Inc.1 Hospital Central de la Defensa Gómez Ulla1 IFOM ETS - The AIRC Institute of Molecular Oncology1 Smith & Nephew, Inc.1 Orchid Pharma Europe GmbH1 AtriCure, Inc.1 Genzyme, a Sanofi Company1 Rigel Pharmaceuticals1 Ciliatech1 Zogenix, Inc.1 Nanordica Medical OU1 Shionogi1 Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)1 Checkpoint Therapeutics, Inc.1 Texas Scottish Rite Hospital for Children1 National University of Singapore1 Ginefiv1 Voronoi, Inc1 Marengo Therapeutics, Inc.1 RayzeBio, Inc.1 Biocon Biologics UK PLC1 QED Therapeutics, a BridgeBio company1 Fidia Farmaceutici s.p.a.1 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 MOMA Therapeutics1 Sumitomo Pharma America, Inc.1 iVascular S.L.U.1 CardioRenal Systems, Inc.1 Hospital General Universitario de Alicante1 Sellas Life Sciences Group1 Peptomyc S.L.1 UCB BIOSCIENCES, Inc.1 Meril Life Sciences Pvt. Ltd.1 Anthos Therapeutics, Inc.1 University Hospital Gregorio Marañón1 University Rovira i Virgili1 Gruppo Italiano Malattie EMatologiche dell'Adulto1 Mount Sinai Hospital, Canada1 Ocus Innovation Ireland Limited1 Rafael Correa-Rocha1 Nova Eye, Inc.1 Leuko Labs, Inc.1 Tenax Therapeutics, Inc.1 Imbria Pharmaceuticals, Inc.1 Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1 Hamilton Health Sciences Corporation1 Ophtec BV1 Pharmacyclics Switzerland GmbH1 Fernando Gómez Muñoz1 AriBio Co., Ltd.1 Abbott Rapid Dx1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 Alfasigma S.p.A.1 Panbela Therapeutics, Inc.1 ReAlta Life Sciences, Inc.1 Dyne Therapeutics1 University of Birmingham1 GO fit Lab- Ingesport1 Institut für Pharmakologie und Präventive Medizin1 Hospital Universitario Getafe1 Spyre Therapeutics, Inc.1 Javelin Medical1 Dinesh Thavendiranathan1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 MaaT Pharma1 Prostate Cancer Clinical Trials Consortium1 Tango Therapeutics, Inc.1 Clínica Nuestra Señora de la Paz1 Medicenna Therapeutics, Inc.1 LMU Klinikum1 C4 Therapeutics, Inc.1 Hospital Infantil Universitario Niño Jesús, Madrid, Spain1 Vastra Gotaland Region1 Enrique Rodilla1 Medicsensors S.L1 European Society of Cardiology1 Copenhagen Trial Unit, Center for Clinical Intervention Research1 Janssen Biotech, Inc.1 eleva GmbH1 University of L'Aquila1 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 Pujol, Aurora, M.D.1 Iksuda Therapeutics Ltd.1 Elexial Research Limited1 Shanghai MicroPort CardioFlow Medtech Co., Ltd.1 NewAmsterdam Pharma1 Pharmazz, Inc.1 Sun Pharmaceutical Industries Limited1 Ultragenyx Pharmaceutical Inc1 Inari Medical1 Trak Health Solutions S.L.1 Tobias Feuchtinger1 Harmony Biosciences Management, Inc.1 Schrödinger, Inc.1 CRISPR Therapeutics AG1 Almirall, S.A.1 University College, London1 Jesús Manuel Nieves Alonso1 Fondazione Ricerca Traslazionale1 Theolytics Limited1 University of Malaga1 University of Jaén1 Stalicla SA1 Investigación en Hemofilia y Fisioterapia1 Fundacion Miguel Servet1 Children's Hospital of Philadelphia1 Integra LifeSciences Corporation1 University of Vigo1 Laboratorios Ozoaqua1 HUYABIO International, LLC.1 SK Life Science, Inc.1 Totus Medicines1 Institut Investigacio Sanitaria Pere Virgili1 Catapult Therapeutics1 X4 Pharmaceuticals1 Asociación Española de Gastroenterología1 Norgine1 AgNovos Healthcare, LLC1 Janux Therapeutics1 Inotrem1 RHEACELL GmbH & Co. KG1 GELLC (Grupo Español de Leucemia Linfocítica Crónica)1 4C Medical Technologies, Inc.1 VDyne, Inc.1 OnKure, Inc.1 Alimera Sciences1 Mural Oncology, Inc1 Casa di Cura IGEA1 ONL Therapeutics1 The POLG Foundation1 Tanabe Pharma America, Inc.1 Aelis Farma1 Siddharth Shanbhag1 Niguarda Hospital1 Merz Pharmaceuticals GmbH1 ParVation Therapeutics, Inc.1 Eidos Therapeutics, a BridgeBio company1 nthalmic Pty Ltd1 Icahn School of Medicine at Mount Sinai1 Shunmei Medical1 Terremoto Biosciences Inc.1 Clínica Rementería1 Oruka Therapeutics, Inc.1 Murdoch Childrens Research Institute1 4TEEN4 Pharmaceuticals GmbH1 VectivBio AG1 Grupo Español de Investigación en Neurooncología1 Dompé Farmaceutici S.p.A1 Iria Grande1 Noucor Health S.A.1 TNC Nutrición Terapéutica S.L.1 Bordeaux Colorectal Institute Academy1 Hansa Biopharma AB1 Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery1 Sirtex Medical1 Exact Sciences Corporation1 Institut Claudius Regaud1 AskBio Inc1 University Hospital, Toulouse1 Cyprus Institute of Neurology and Genetics1 LeMaitre Vascular1 Alcon Research1 Pheon Therapeutics1 Teoxane SA1 Cerevance1 iECURE, Inc.1 Arbor Research Collaborative for Health1 Annetine Gelijns1 LeonaBio1 Federal University of São Paulo1 CEBIOTEX1 Advanced Accelerator Applications1 Charite University, Berlin, Germany1 Centessa Pharmaceuticals (UK) Limited1 Jimena del Castillo1 Margan Biotech1 Alejandro Cruz Utrilla1 University Hospital, Grenoble1 Hospital Universitari de Bellvitge1 Medical University of Graz1 Fundación IVI1 Kardigan, Inc.1 Gabriel Riva1 Mestag Therapeutics Limited1 Probelte Pharma S.L.U.1 Kedrion S.p.A.1 Medical University of South Carolina1 SecuraBio1 WhiteSwell, Limited1 Akcea Therapeutics1 Diagram B.V.1 Nykode Therapeutics ASA1 Integrative Research Laboratories AB1 Highlight Therapeutics1 Acrotech Biopharma Inc.1 Quironsalud1 Ceric Sàrl1 National Cancer Institute (NCI)1 Medtronic MiniMed, Inc.1 dr. Laura C. G. de Graaff-Herder1 Viatris Innovation GmbH1 Acrivon Therapeutics1 Curium US LLC1 Womed1 Grifols Therapeutics LLC1 Alterome Therapeutics, Inc.1 Moleculin Biotech, Inc.1 Emalex Biosciences Inc.1 Universitat Oberta de Catalunya1 Ascendis Pharma A/S1 VisionCare, Inc.1 Uniquity One (UNI)1 TransThera Sciences (Nanjing), Inc.1 Milestone Pharmaceuticals Inc.1 Lourdes Montero Cruces1 GBG Forschungs GmbH1 Miguel Sanchez Garcia1 invoX Pharma Limited1 Candelas Lopez Lopez1 Hedera Dx SA1 Children's Oncology Group1 Alliance for Clinical Trials in Oncology1 Kartos Therapeutics, Inc.1 EyeBiotech Ltd.1 Francisco J. Blanco1 Ventus Therapeutics U.S., Inc.1 Kyowa Kirin Co., Ltd.1 North Eastern German Society of Gynaecological Oncology1 Vifor Fresenius Medical Care Renal Pharma1 Theravance Biopharma1 Innoskel1 Miguel López Moreno1 Inna Chen, MD1 Kymera Therapeutics, Inc.1 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1 Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Cellectar Biosciences, Inc.1 German Heart Institute1 CNS Pharmaceuticals, Inc.1 Memorial Sloan Kettering Cancer Center1 Ottawa Heart Institute Research Corporation1 Consorci Sanitari de l'Alt Penedès i Garraf1 Philippe ROUSSELOT1 TORL Biotherapeutics, LLC1 Zoll Medical Corporation1 Lyx Institute1 Miltenyi Biomedicine GmbH1 Fondazione Ricerca e Innovazione Cardiovascolare ETS1 Zura Bio Inc1 Apollomics Inc.1 CHDI Foundation, Inc.1 Laboratoires Arkopharma1 Rna Diagnostics Inc.1 PedNet Haemophilia Research Foundation1 SymBio Pharmaceuticals1 IVI Madrid1 Aarhus University Hospital Skejby1 Zealand Pharma1 MED-EL Elektromedizinische Geräte GmbH1 Casper Rokx1 DualityBio Inc.1 Tenaya Therapeutics1 Toralf Reimer, MD PhD1 Ultrasound-Innovation Medtech, S.L.1 Protagonist Therapeutics, Inc.1 IRCCS San Raffaele Roma1 Skyhawk Therapeutics, Inc.1 International Extranodal Lymphoma Study Group (IELSG)1 Inossia AB1 Astellas Gene Therapies1 Silence Therapeutics plc1 Santhera Pharmaceuticals1 Qurient Co., Ltd.1 OrbusNeich1 Francisco Andres de la Gala1 International CTEPH Association1 Weill Medical College of Cornell University1 CGBio Inc.1 Centre Hospitalier Universitaire de Besancon1 GCP-Service International West GmbH1 CUTISS AG1 Baxalta now part of Shire1 Iperboreal Pharma Srl1 Dolores Lopez Romero1 Redx Pharma Ltd1 35Pharma Inc., a GSK company1 Region Skane1 Paragonix Technologies1 Nouscom SRL1 Air Liquide Healthcare Spain1 Dairy Goat Co-operative (N.Z.) Limited1 Federation Francophone de Cancerologie Digestive1 Citryll BV1 Vedanta Biosciences, Inc.1 ElmediX1 Acumen Pharmaceuticals1 Inmunova S.A.1 University Health Network, Toronto1 Tectonic Therapeutic1 Persei Vivarium1 Association for Innovation and Biomedical Research on Light and Image1 Devintec Sagl1 Cardenal Herrera University1 Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas1 Juan Francisco Delgado Jimenez1 Orchestra BioMed, Inc1 Skin Tech Pharma Group S.L.U.1 Alfredo Lerín Calvo1 PhenoNet, Inc.1 Vall d'Hebron Institute of Oncology1 Crystalys Therapeutics1 Stoke Therapeutics, Inc1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Z Optics, Inc.1 Kyowa Kirin, Inc.1 K36 Therapeutics, Inc.1 Inventiva Pharma1 Ottimo Pharma Limited1 Erasca, Inc.1 Neuron, Spain1 Universitat de les Illes Balears1 AllRock Bio, Inc.1 Treeline Biosciences, Inc.1 AlgoTherapeutix1 University Hospital, Antwerp1 Arrow Development1 PENTA Foundation1 CellCentric Ltd.1 Pulmovant, Inc.1 Intra-Cellular Therapies, Inc.1 Nimbus Wadjet, Inc.1 Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares1 Myopowers Medical Technologies France SAS1 Eagle Pharmaceuticals, Inc.1 University Hospital Tuebingen1 Escuela Universitaria de Fisioterapia de la Once1 Elios Vision, Inc.1 Synthekine1 Hospital Universitario Central de Asturias1 Ascendis Pharma Oncology Division A/S1 Forma Therapeutics, Inc.1 CoreAalst BV1 Biosensors Europe SA1 Indizen Optical Technologies, S.L.U.1 Women's Cancer Study Group GmbH1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 AVEO Pharmaceuticals, Inc.1 Exciva GmbH1 José Carlos Marín Gabriel1 Fundacion Oncosur1 Institut National de la Santé Et de la Recherche Médicale, France1 Fytexia1 Epizyme, Inc.1 Iambic Therapeutics, Inc1 pharmaand GmbH1 Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 Incyte Biosciences International Sàrl1 Implantica CE Reflux Ltd.1 Abbisko Therapeutics Co, Ltd1 Fundacion IMIM1 Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús1 M.A. Med Alliance S.A.1 Cordis US Corp.1 University of California, Los Angeles1 Abalos Therapeutics GmbH1 Karolinska Institutet1 Dimerix Bioscience Pty Ltd1 Brigham and Women's Hospital1 Medical University of Vienna1 Boston Children's Hospital1 Xinnate AB1 Cardiac Dimensions, Inc.1 Gossamer Bio USA, Inc.1 Olatec Therapeutics, Inc.1 Minoryx Therapeutics, S.L.1 Vida Fertility Institute1 Airway Therapeutics, Inc.1 Italfarmaco1 Microbiotica Ltd1 German CLL Study Group1 RapidPulse, Inc1 Aida Frías González1 DEO NV1 Accession Therapeutics Limited1 T3 Pharmaceuticals AG1 María Belén Martínez Luna1 Shanghai Junshi Bioscience Co., Ltd.1 Instituto Ramón y Cajal de Investigación Sanitaria1 Contineum Therapeutics1 InSightec1 Prelude Therapeutics Incorporated1 Centro Nacional de Investigaciones Oncologicas CARLOS III1 Universidad de Granada1 Esther Nova1 VZW Cardiovascular Research Center Aalst1 Crescent Biopharma, Inc.1 XVIVO Perfusion1 University Hospital, Geneva1 Danone Global Research & Innovation Center1 Mediar Therapeutics1 IntraBio Inc1 Grupo Espanol Multidisciplinario del Cancer Digestivo1 Corxel Pharmaceuticals1 Gyroscope Therapeutics Limited1 Prof. Dr. Martin Wabitsch1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Meiji Pharma Spain S.A.1 Adcytherix SAS1 Duke Street Bio Ltd1 Infant Bacterial Therapeutics1 Zimmer Biomet1 Partner Therapeutics, Inc.1 Asociación Española para el Estudio de la Menopausia1 Ichnos Sciences SA1 Fundación Iniciativa para las Neurociencias (FINCE)1 MeiraGTx Ocular UK Ltd1 Chiesi España, S.A.U.1 HotSpot Therapeutics, Inc1 Centro per la Lotta Contro l'Infarto - Fondazione Onlus1 Samsung Bioepis Co., Ltd.1 Intensity Therapeutics, Inc.1 Wroclaw University of Health and Sport Sciences1 Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas1 Portal Therapeutics, Inc.1 Sara Casanova Prieto1 University of Barcelona1 PMV Pharmaceuticals, Inc1 Fore Biotherapeutics1 Arvinas Inc.1 COMPASS Pathways1 Anaconda Biomed S.L.1 Hospital Clínico Universitario de Valladolid1 Electra Therapeutics Inc.1 Telios Pharma, Inc.1 NVT GmbH1 Elion Therapeutics, Inc.1 CarThera1 AdventHealth1 ReSport Clinic1 OncoC4, Inc.1 Fundación Hipercolesterolemia Familiar1 OncoVerity, Inc.1 Cartesian Therapeutics1 University of Manchester1 Epics Therapeutics1 Guerbet1 Ivy Brain Tumor Center1 Annexon, Inc.1 FCRE (Foundation for Cardiovascular Research and Education)1 Neuron23 Inc.1 Day One Biopharmaceuticals, Inc.1 Deutsches Herzzentrum Muenchen1 ImCheck Therapeutics, an Ipsen company1 Priovant Therapeutics, Inc.1 Assistance Publique - Hôpitaux de Paris1 Abivax S.A.1 Vecmedical Spain, S.L.1 Alumis Inc1 Universitätsklinikum Hamburg-Eppendorf1 Servier Affaires Médicales1 GT Metabolic Solutions, Inc.1 Stryker Craniomaxillofacial1 Friedreich's Ataxia Research Alliance1 Climb Bio, Inc.1 Camurus AB1 Marc van Sambeek1 University of Alcala1 BioLineRx, Ltd.1 Jules Bordet Institute1 University of Campania Luigi Vanvitelli1 Aesculap AG1 One-carbon Therapeutics AB1 Biobizkaia Health Research Institute1 BioAegis Therapeutics Inc.1 ReCor Medical, Inc.1 Epygon1 IRCCS San Raffaele1 Rapamycin Holdings Inc.1 Inhibikase Therapeutics1 Universidad Antonio de Nebrija1 Glaukos Corporation1 Enterome1 Fernando Fernandez Velazquez1 Fundación para el Progreso de la Oncología en Cantabria1 Menarini Group1 Bold Therapeutics, Inc.1 Inhatarget Therapeutics1 Elevar Therapeutics1 Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 St George's, University of London1 Javier P. Gisbert1 Henares University Hospital1 Fundación para la Investigación Biosanitaria del Principado de Asturias1 Beeline Medicines Corporation1 Genespire Srl1 MediWound Ltd1 University of Exeter1 Technical University of Munich1 dr. M.J.N.L. Benders1 Mayo Clinic1 Britannia Pharmaceuticals Ltd.1 Fundacio Puigvert1 Technophage, SA1 Technische Universität Dresden1 Abcentra1 Rethink Medical SL1 CDR-Life AG1 Alligator Bioscience AB1 Clear sponsor filter
Target enrolment
to

Trials with a site in Madrid

17 of 5925 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Bayer
Phase 3
117
Madrid, Barcelona, Córdoba, Málaga, Seville
2026-06-01
Recruiting
Bayer
Phase 1
130
Barcelona, Madrid
2026-04-07
Recruiting
Bayer
Phase 3
111
Esplugues de Llobregat, Córdoba, Madrid, Málaga, Seville, Barcelona
2025-11-19
Active, closed
Bayer
Phase 2
60
Barcelona, Alcázar de San Juan, Madrid, Seville
2025-11-19
Recruiting
Bayer
Phase 1/2
450
Barcelona, Pamplona, Logroño, Madrid, Pozuelo de Alarcón, Málaga, Valencia
2025-03-21
Recruiting
Bayer
Phase 1
148
Barcelona, Madrid, Pamplona
2025-02-28
Active, closed
Bayer
Phase 3
985
Santiago de Compostela, Santander, Barcelona, Cadiz, Madrid, Málaga, Murcia, Seville
2023-04-03
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Santiago de Compostela, Aravaca, Barcelona, Granada, Madrid, Seville, Valencia
2022-10-14
Recruiting
Bayer
Phase 1/2
430
L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga, Valencia
2021-10-25
Active, closed
Bayer
Phase 4
654
Santiago de Compostela, Palma de Mallorca, Badalona, Castellon, Girona, Madrid, Majadahonda, Oviedo
2020-11-09
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-spain/city/madrid

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,925 studies in total at the last sync on 20 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Madrid that also match the filters currently applied.

How many clinical trials are recruiting in Madrid?

9 of the 17 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Madrid), 17 studies
PhaseStudiesRecruitingShare
Phase 37441.2%
Phase 14223.5%
Phase 23117.6%
Phase 1/22211.8%
Phase 4105.9%

Most active sponsors

Lead sponsors with the most studies (Madrid)
Lead sponsorStudiesRecruiting
Bayer179
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.